French consensus procedure for neuropsychological assessment in multiple sclerosis - 13/07/24

Doi : 10.1016/j.neurol.2024.06.005

C. Jougleux ^a,^{^{1
Jointly article's first authors.},}⁎ , H. Joly ^b,^c,^d,^{^{1
Jointly article's first authors.}}, H. Brissard ^d,^e, B. Lenne ^f, S. François ^g, F. Hamelin ^h, N. Derache ⁱ, J. Morin ^j, F. Reuter ^k,^l, R. Colamarino ^m, A. Ruet ^j,ⁿ
^a Service de neurologie et pathologies neuro-inflammatoires, Clinique neurologique, CRC SEP, CHU de Lille, Lille, France
^b Service de neurologie, CHU Pasteur 2, CRC SEP, Nice, France
^c UR2CA-URRIS, université Nice Côte d’Azur, Nice, France
^d CNRS, IMoPA, université de Lorraine, Nancy, France
^e Service de neurologie, CHRU de Nancy, Nancy, France
^f Groupement des hôpitaux de l’institut catholique de Lille (GHICL), Neurology Department, Lille, France
^g Service de neurologie, CHU de Nantes, Nantes, France
^h Structure régionale NeuroSEP Synapse, Le Vésinet, France
ⁱ Department of Neurology, centre hospitalier universitaire de Caen Normandie, Caen, France
^j Service de neurologie pathologie inflammatoire du système nerveux central, CRC SEP, CHU Pellegrin, CHU de Bordeaux, Bordeaux, France
^k Service de neurologie, hôpital de la Timone, AP–HM, pôle de neurosciences cliniques, Marseille, France
^l CEMEREM, Aix Marseille université, CNRS, CRMBM, UMR 7339, Marseille, France
^m Service de neurologie, CH d’Antibes, Antibes, France
ⁿ Inserm U1215, Neurocentre Magendie, université de Bordeaux, Bordeaux, France

^⁎Corresponding author. Service de neurologie et pathologies neuro-inflammatoires, Clinique neurologique, CRC SEP, CHU de Lille, Lille, France.Service de neurologie et pathologies neuro-inflammatoires, Clinique neurologique, CRC SEP, CHU de LilleLilleFrance

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Saturday 13 July 2024

Abstract

Cognitive impairment is one of the invisible symptoms of Multiple sclerosis (MS), which could be associated with depression, unemployment, reduced social interaction, inability to drive, and compromised quality of life. Moreover, the presence of cognitive impairment can be considered as a long-term prognostic factor and in the follow-up of disability. So, cognitive assessment is a crucial element in clinical follow-up of patients with MS (pwMS). International recommendations mention the use of the Brief International Cognitive Assessment in MS (BICAMS). The BICAMS, that has been recently validated in French is a brief non-exhaustive assessment, developed as a short screening battery, hence needing other supplemented tests. The present paper aims to propose a consensus, approved by expert French consensus from the Cognition group of the SF-SEP (sfsep.org/ [Société Francophone de la Sclérose en Plaques]), for cognitive assessment of pwMS suggesting the tools that should be used in order to apprehend the other cognitive impairments that could appear in MS.

Le texte complet de cet article est disponible en PDF.

Keywords : Multiple sclerosis, Cognitive assessment, French consensus